Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-09-04-Speech-4-018"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20080904.4.4-018"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
Madam President, I usually say that the EU must become narrower but sharper, in other words that we should focus our actions while also respecting subsidiarity. This action plan is exactly this kind of area. I would like to raise a few things which our rapporteur Mrs Ries addresses in her report. Her criticism of the lack of quantified objectives and indicators is very serious. We must add to the action plan. The criticism from Mrs Ries and several other Members of the fact that there are insufficient precautionary measures is serious. It is directed at this material and we must take it into account in our ongoing work.
I would particularly like to highlight three areas: weak groups, endemic disease and the link between climate and health. We must become much better at seeing the differences in treatment and medication of adults and children, and women and men. It is a scandal that this is still not self-evident and has not already been implemented in medical research and treatment.
The work which has started on patient mobility in the internal market is incredibly important to different patient groups, e.g. those with neck injuries, where different standards of treatment are found in different Member States.
I welcome the focus of the French Presidency on Alzheimer’s disease, one of our major endemic diseases, but we also need a coordinated approach for diabetes, asthma and rheumatism, to name but a few examples. This is also the case for working environment-related injuries.
We are now witnessing a trend in Europe and worldwide of more pandemics and the greater spreading of viruses, bacteria and parasites in a manner which has not been seen in a very long time. Much of this is naturally related to climate change.
Antibiotic-resistant bacteria mean medicines and treatments are not working and this is one of our most urgent health problems. It is a shame that the development of new antibiotics has largely ground to a halt in the major pharmaceutical companies. I hope that the Presidency and the Commission will tackle this very serious and major problem as soon as possible!
We also need an analysis of different climate change scenarios. What effect would a global increase in temperature of two degrees, four degrees or even more have on health in Europe? No such material is available today. If we are to be able to make concrete and good decisions on the climate change package, we also need reliable material on the various climate scenarios we will have to cope with in the future."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples